Innoplexus is a company that focuses on the use of artificial intelligence and data in the healthcare and pharmaceutical industries. The company offers a range of services, including drug discovery and development, using proprietary artificial intelligence and machine learning technologies to provide insights from global data. These insights are used to understand the complexity of diseases and develop effective treatment strategies. The company primarily serves the pharmaceutical and biotech industries. It was founded in 2015 and is based in Eschborn, Germany.
Innoplexus's Products & Differentiators
Software Platform & Royalty partnerships
8 modules to support pharma/biotech decision making from target identification, indication prioritization, de novo drug design and clinical trial design
Expert Collections containing Innoplexus
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Innoplexus is included in 3 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Drug Discovery Tech Market Map
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
Innoplexus has filed 96 patents.
Drug discovery, Blockchains, Pharmaceutical industry, Identifiers, Cryptocurrencies
Drug discovery, Blockchains, Pharmaceutical industry, Identifiers, Cryptocurrencies
Latest Innoplexus News
Oct 23, 2023
Major Players Shaping the AI in Clinical Trials Market Key players in the AI in clinical trials market include Medable Inc., PathAI inc., Saama Technologies Inc., Apellis Pharmaceuticals Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc. Revolutionizing Clinical Trials with Innovative Products The AI in clinical trials market is witnessing a significant trend toward innovative product offerings. Leading companies in this sector are introducing groundbreaking products to maintain their competitive edge. For example, in January 2023, Elligo Health Research Inc., a US-based healthcare-enabling research organization, unveiled DataAI Connect, a cutting-edge data and technology platform designed to facilitate data-driven clinical research. This comprehensive platform simplifies data collection, management, analysis, and sharing of real-world patient data. Get A Free Sample Of The Global Artificial Intelligence (AI) In Clinical Trials Market Report Regional Dynamics and Market Segmentation In 2022, North America emerged as the largest region in the AI in clinical trials market and is expected to be the fastest-growing region in the forecast period. The global artificial intelligence (AI) in clinical trials market is meticulously segmented across various dimensions: By Offering: Software, Services By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring By Application: Oncology, Neurological Disease and Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, and Other Applications By End-User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Other End-Users The Global AI in Clinical Trials Market Report 2023 is an invaluable resource for a diverse range of stakeholders. Businesses can leverage the insights within the report to make informed strategic decisions, identify avenues for growth, and align their strategies with evolving market dynamics. Investors will find the report essential for pinpointing areas of potential investment and forecasting future market trends. In summary, the artificial intelligence (AI) in clinical trials market report empowers stakeholders from various sectors to navigate the complex landscape of AI in clinical trials with confidence. Artificial Intelligence (AI) In Clinical Trials Global Market Report 2023 by The Business Research Company provides insights on the artificial intelligence (AI) in clinical trials market size, artificial intelligence (AI) in clinical trials market segments, artificial intelligence (AI) in clinical trials market trends, drivers and restraints, major competitors’ market positioning, revenues and market shares. The Business Research Company has published over 6,500+ industry reports, covering more than 2,500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Check Out Similar Market Intelligence Reports By The Business Research Company: Artificial Intelligence Services Global Market Report 2023 Learn More About The Business Research Company The Business Research Company is a market intelligence firm pioneering in company, market, and consumer research. With offices all around the world, TBRC has specialist consultants in a variety of fields, including manufacturing, healthcare, financial services, chemicals, and technology. Global Market Model – World’s Most Comprehensive Database The Business Research Company’s flagship product, Global Market Model , is a market intelligence platform covering various macroeconomic indicators and metrics across 58 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps. Contact Data The Business Research CompanyEurope: +44 207 1930 708Asia: +91 8897263534Americas: +1 315 623 0293Email: firstname.lastname@example.orgFollow us on:LinkedIn: https://in.linkedin.com/company/the-business-research-companyTwitter: https://twitter.com/tbrc_infoFacebook: https://www.facebook.com/TheBusinessResearchCompanyYouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQBlog: https://blog.tbrc.info/Healthcare Blog: https://healthcareresearchreports.com/Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Innoplexus Frequently Asked Questions (FAQ)
When was Innoplexus founded?
Innoplexus was founded in 2015.
Where is Innoplexus's headquarters?
Innoplexus's headquarters is located at Frankfurter Strasse 63-69, Eschborn.
What is Innoplexus's latest funding round?
Innoplexus's latest funding round is Series C.
Who are the investors of Innoplexus?
Investors of Innoplexus include FinLab EOS VC, NVIDIA Inception Program and HCS Beteiligungsgesellschaft.
Who are Innoplexus's competitors?
Competitors of Innoplexus include Biorelate, nference, BenevolentAI, Nyquist Data, Saama Technologies and 7 more.
What products does Innoplexus offer?
Innoplexus's products include Software Platform & Royalty partnerships.
Compare Innoplexus to Competitors
Insitro focuses on drug discovery and development. The company's main services involve the use of machine learning and high-throughput biology to predict successful paths for medicine creation. It aims to avoid costly failures in pharmaceutical research and development (R&D). Insitro primarily sells to the healthcare industry. It was founded in 2018 and is based in South San Francisco, California.
Causaly offers an operating system for biomedical and health data. It is an AI platform to help researchers accelerate the development and testing of drugs. The company was founded in 2018 and is based in London, United Kingdom.
InveniAI uses AI to provide context in healthcare and life sciences applications. EvolverAI is InveniAI's augmented intelligence platform that combines human intuition based on experience and expertise with the comprehensiveness and scale of artificial intelligence. EvolverAI combines Big Data technology with machine learning to present to human experts massive and complex data sets in a manner that allow humans to decipher patterns and enables the generation of hypotheses. EvolverAI combines the tenets of deductive, inductive and abductive research in this journey of discovery. PharmGPS is InveniAI's Big Data platform applied to understanding how drugs work and which of them are useful in satisfying unmet medical needs. PharmGPS has collated and crystallized the cumulative wisdom of pharmaceutical and drug development research to identify the drugs that are most likely to succeed in the regulatory process and satisfy patients' needs. It utilizes machine learning and big data approaches to predict future potential of drugs that are still in early stages of clinical development.
Galactica Biotech is a company that focuses on the pharmaceutical industry, specifically in the area of drug discovery. The company offers services such as drug repurposing and repositioning, using advanced analytical methods including machine learning to identify new uses for existing molecules. This process aims to reduce risk for patients and decrease time and cost for companies. It was founded in 2017 and is based in Cork, Ireland.
BioMap focuses on leveraging artificial intelligence (AI) to advance life sciences. The company develops AI Foundation Models to understand and predict complex biological behaviors and creates task models for various life science applications, including therapeutic antibodies and industrial enzymes. BioMap primarily serves the biotechnology and pharmaceutical industries with its AI-driven solutions. It was founded in 2020 and is based in Palo Alto, California.
Stardog develops an enterprise knowledge graph platform. It uses smart graph technology to unify heterogeneous, disparate data across the enterprise. The company's platform helps organizations unify data into a graph-based model that allows business logic and data sources to evolve independently. Stardog was formerly known as Clark & Parsia. The company was founded in 2015 and is based in Arlington, Virginia.